The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

2019 Prizes and Awards

View photos, reflections and biographies from this year's prize winners. Continually updated, so check back often.
Read More

Pocket Prescriber Psychiatry

The new Pocket Prescriber Psychiatry book is out now.
Read More

Visualising Psychotropic Medicine (VPM)

Presenting what can be a complex set of data in a useful and engaging way
Read More

Online CPD Resource

RCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Read More

Fundamentals of Clinical Psychopharmacology

Buy a discounted copy of the latest edition of Fundamentals of Clinical Psychopharmacology
Read More

The Ten Secrets of Success in Science

View Professor Trevor Robbins presenting his top tips
Read More

Neuroscience-based Nomenclature (NbN) for JoP

Journal of Psychopharmacology chosen to trial new NbN
Read More

Fundamentals Wins BMA Award

Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Read More

Not all in the mind – the contribution of brain science to modern psychiatry

Watch Prof David Nutt's lecture in Manchester on YouTube
Read More

Membership

Benefits of BAP membership include:

  • FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
  • Reduced registration fees for the annual Summer Meeting.
  • Half price subscription to the Online CPD Resource.
  • Eligibility for prizes and awards.
  • Student bursaries for the BAP Summer Meeting and international conferences.
  • Reduced registration fees for selected partner association events.
  • 50% OFF Royal Society of Biology membership (Read more)
  • BAP Newsletter.
  • Voting for BAP Officers and Council (full members only).
  • Being part of one of the largest national psychopharmacology associations in the world.

Meetings and Events

All Events

5th January 2020 Oxford Short Course in Experimental Medicine for Mental Health - OxCEMM Warneford Hospital, Warneford Lane, Oxford
15th January 2020 Neuroscience@Nottingham Day University of Nottingham
23rd January 2020 Anxiety Disorders The Bristol Hotel, Prince Street, Bristol

Clinical Certificate | Masterclasses | Non-Clinical Certificate

Articles

Nocturnal light exposure and mood disorders
By Antonio Gonzalez
Posted on 9th December 2019

Milan, Italy in 2015Introduction For millions of years prior to the widespread use of electricity, humans were exposed to minimal amounts of nocturnal light in comparison to modern times. During clear starry nights, light exposure was limited to around 0.001 lux, and no artificial light sources existed until the use of fire, an ability that is estimated to […]


Deciphering the biology behind psychiatric risk genes
By Simon Trent
Posted on 12th November 2019

Genetic studies that scan the genomes of psychiatric patients are becoming increasingly good at identifying ‘risk genes’ associated with disorders such as schizophrenia, autism and intellectual disability. However, we still know very little about the biological actions and pathways that are being genetically encoded within these risk genes. Understanding the biology behind the vulnerability to […]


The neuroeconomics of drug use
By Will Lawn
Posted on 15th October 2019

Neuroeconomics is an interdisciplinary research field, which emerged in the early 2000s, made up of a combination of cognitive neuroscience, psychology and behavioural economics. The primary aims of neuroeconomics are to: identify which brain regions encode subjective value (Chib, Rangel, Shimojo, & O’Doherty, 2009; Peters & Büchel, 2010); understand the brain mechanisms that underpin decision-making […]


See more articles

Media

Ravi Das
One-off ketamine dose may reduce heavy drinking, say scientists
Ravi speaks to the Guardian about a new study using ketamine to help heavy drinkers
26th November 2019

Hip Hop Psych
Welcome to the World of George the Poet
Akeem Sule and Becky Inkster (Hip Hop Psych) interview George the poet on hiphop and mental health
2nd November 2019

Andrew Mayers
5 News Special - Mental Health - Breaking the Silence
Andrew focuses specifically on fathers in a Channel 5 News programme dedicated to men’s mental health.
30th July 2019

Annabel Walsh (MQ IDEA Project)
MQ Open Mind Podcast
Helen Fisher and MQ ambassador John discuss risk for developing depression and the Identifying Depression Early in Adolescence (IDEA) Project.
29th July 2019

Barbara Sahakian
Understanding the infant-parent connection: summary interview
Barbara Sahakian interviews developmental cognitive neuroscientist Dr Victoria Leong about her research with mothers and babies exploring how they naturally synchronise during social interactions, helping babies learn from their mothers.
26th July 2019

See more media

News

2019 Prizes and Awards
25th July 2019

View all award winners from this year's meeting. Photos, reflections and biographies are being continually updated, so check back often.
View this year's prize winners
Street Drugs Conference Wales 2019: Is the Dragon Still Smoking?
13th July 2019

Overview of the latest Street Drugs Conference in Wales on 25th June.
Read the review
REF2021 Success
4th February 2019

Prof Allan Young, Prof Jeremy Hall and Prof Helen Cassaday selected to join REF2021 panel 4: Psychology, Psychiatry and Neuroscience
Read More
Professor David Nutt Wins Academic Honorary Award in Istanbul
9th November 2018

Professor David Nutt has won the Academic Honorary Award at the International Crime and Punishment Film Festival in Istanbul
Read More

See more news

Twitter


Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.